Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+14.3M
-
Total reported value, excl. options
-
$25.2M
-
Value change
-
+$12.9M
-
Put/Call ratio
-
1.23
-
Number of buys
-
20
-
Number of sells
-
-43
-
Price
-
$0.95
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q2 2022
74 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q2 2022.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 144M outstanding shares and own 18.52% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (4.78M shares), Alyeska Investment Group, L.P. (4.36M shares), ORBIMED ADVISORS LLC (4.25M shares), FMR LLC (4.01M shares), Point72 Asset Management, L.P. (2.84M shares), Knoll Capital Management, LLC (1.08M shares), Rock Springs Capital Management LP (702K shares), Empery Asset Management, LP (675K shares), VANGUARD GROUP INC (514K shares), and BlackRock Inc. (489K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.